RESUMO
Ferritin is a sub-family of iron binding proteins that form multi-subunit nanotype iron storage structures and prevent oxidative stress induced apoptosis. Here we describe the identification and characterization of human ferritin, heavy polypeptide 1 (FTH1) as a suppressor of the pro-apoptotic murine Bax sequence in yeast. In addition we demonstrate that FTH1 is a general pro-survival sequence since it also prevents the cell death inducing effects of copper when heterologously expressed in yeast. Although ferritins are phylogenetically widely distributed and are present in most species of Bacteria, Archaea and Eukarya, ferritin is conspicuously absent in most fungal species including Saccharomyces cerevisiae. An in silico analysis of the yeast proteome lead to the identification of the 161 residue RGI1 (YER067W) encoded protein as a candidate for being a yeast ferritin. In addition to sharing 20% sequence identity with the 183 residue FTH1, RGI1 also has similar pro-survival properties as ferritin when overexpressed in yeast. Analysis of recombinant protein by SDS-PAGE and by electron microscopy revealed the expected formation of higher-order structures for FTH1 that was not observed with Rgi1p. Further analysis revealed that cells overexpressing RGI1 do not show increased resistance to iron toxicity and do not have enhanced capacity to store iron. In contrast, cells lacking RGI1 were found to be hypersensitive to the toxic effects of iron. Overall, our results suggest that Rgi1p is a novel pro-survival protein whose function is not related to ferritin but nevertheless it may have a role in regulating yeast sensitivity to iron stress.
Assuntos
Sulfato de Cobre/farmacologia , Ferritinas/fisiologia , Proteínas de Saccharomyces cerevisiae/fisiologia , Saccharomyces cerevisiae/fisiologia , Proteína X Associada a bcl-2/fisiologia , Sequência de Aminoácidos , Animais , Cloretos/farmacologia , Compostos Férricos/farmacologia , Ferritinas/química , Humanos , Camundongos , Viabilidade Microbiana , Dados de Sequência Molecular , Oxirredutases , Proteínas de Saccharomyces cerevisiae/química , Homologia de Sequência de Aminoácidos , Estresse FisiológicoRESUMO
Mitochondrial outer membrane permeabilization is a watershed event in the process of apoptosis, which is tightly regulated by a series of pro- and anti-apoptotic proteins belonging to the BCL-2 family, each characteristically possessing a BCL-2 homology domain 3 (BH3). Here, we identify a yeast protein (Ybh3p) that interacts with BCL-X(L) and harbours a functional BH3 domain. Upon lethal insult, Ybh3p translocates to mitochondria and triggers BH3 domain-dependent apoptosis. Ybh3p induces cell death and disruption of the mitochondrial transmembrane potential via the mitochondrial phosphate carrier Mir1p. Deletion of Mir1p and depletion of its human orthologue (SLC25A3/PHC) abolish stress-induced mitochondrial targeting of Ybh3p in yeast and that of BAX in human cells, respectively. Yeast cells lacking YBH3 display prolonged chronological and replicative lifespans and resistance to apoptosis induction. Thus, the yeast genome encodes a functional BH3 domain that induces cell death through phylogenetically conserved mechanisms.
Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Apoptose , Mitocôndrias/metabolismo , Fragmentos de Peptídeos/farmacologia , Proteínas Proto-Oncogênicas/farmacologia , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/metabolismo , Transdução de Sinais , Sequência de Aminoácidos , Animais , Proteínas Reguladoras de Apoptose/antagonistas & inibidores , Proteínas Reguladoras de Apoptose/genética , Western Blotting , Neoplasias Ósseas/genética , Neoplasias Ósseas/metabolismo , Ciclo Celular , Citometria de Fluxo , Humanos , Imunoprecipitação , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/metabolismo , Potencial da Membrana Mitocondrial , Camundongos , Mitocôndrias/genética , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , Dados de Sequência Molecular , Proteínas de Transporte de Fosfato/genética , Proteínas de Transporte de Fosfato/metabolismo , RNA Mensageiro/genética , RNA Interferente Pequeno/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/antagonistas & inibidores , Proteínas de Saccharomyces cerevisiae/genética , Homologia de Sequência de Aminoácidos , Células Tumorais Cultivadas , Proteína X Associada a bcl-2/genética , Proteína X Associada a bcl-2/metabolismo , Proteína bcl-X/genética , Proteína bcl-X/metabolismoRESUMO
Pathological neuronal inclusions of the 43-kDa TAR DNA-binding protein (TDP-43) are implicated in dementia and motor neuron disorders; however, the molecular mechanisms of the underlying cell loss remain poorly understood. Here we used a yeast model to elucidate cell death mechanisms upon expression of human TDP-43. TDP-43-expressing cells displayed markedly increased markers of oxidative stress, apoptosis, and necrosis. Cytotoxicity was dose- and age-dependent and was potentiated upon expression of disease-associated variants. TDP-43 was localized in perimitochondrial aggregate-like foci, which correlated with cytotoxicity. Although the deleterious effects of TDP-43 were significantly decreased in cells lacking functional mitochondria, cell death depended neither on the mitochondrial cell death proteins apoptosis-inducing factor, endonuclease G, and cytochrome c nor on the activity of cell death proteases like the yeast caspase 1. In contrast, impairment of the respiratory chain attenuated the lethality upon TDP-43 expression with a stringent correlation between cytotoxicity and the degree of respiratory capacity or mitochondrial DNA stability. Consistently, an increase in the respiratory capacity of yeast resulted in enhanced TDP-43-triggered cytotoxicity, oxidative stress, and cell death markers. These data demonstrate that mitochondria and oxidative stress are important to TDP-43-triggered cell death in yeast and may suggest a similar role in human TDP-43 pathologies.
Assuntos
DNA Fúngico/metabolismo , DNA Mitocondrial/metabolismo , Proteínas de Ligação a DNA/biossíntese , Mitocôndrias/metabolismo , Estresse Oxidativo , Proteínas Recombinantes/biossíntese , Saccharomyces cerevisiae/metabolismo , Proteinopatias TDP-43/metabolismo , Morte Celular/genética , DNA Fúngico/genética , DNA Mitocondrial/genética , Proteínas de Ligação a DNA/genética , Humanos , Mitocôndrias/genética , Consumo de Oxigênio/genética , Proteínas Recombinantes/genética , Saccharomyces cerevisiae/genética , Proteinopatias TDP-43/genética , Proteinopatias TDP-43/patologiaRESUMO
The identification of novel anti-apoptotic sequences has lead to new insights into the mechanisms involved in regulating different forms of programmed cell death. For example, the anti-apoptotic function of free radical scavenging proteins supports the pro-apoptotic function of Reactive Oxygen Species (ROS). Using yeast as a model of eukaryotic mitochondrial apoptosis, we show that a cDNA corresponding to the mitochondrial variant of the human DUT gene (DUT-M) encoding the deoxyuridine triphosphatase (dUTPase) enzyme can prevent apoptosis in yeast in response to internal (Bax expression) and to exogenous (H(2)O(2) and cadmium) stresses. Of interest, cell death was not prevented under culture conditions modeling chronological aging, suggesting that DUT-M only protects dividing cells. The anti-apoptotic function of DUT-M was confirmed by demonstrating that an increase in dUTPase protein levels is sufficient to confer increased resistance to H(2)O(2) in cultured C2C12 mouse skeletal myoblasts. Given that the function of dUTPase is to decrease the levels of dUTP, our results strongly support an emerging role for dUTP as a pro-apoptotic second messenger in the same vein as ROS and ceramide.
Assuntos
Apoptose , Mioblastos/metabolismo , Pirofosfatases/metabolismo , Saccharomyces cerevisiae/metabolismo , Sistemas do Segundo Mensageiro/fisiologia , Proteína X Associada a bcl-2/metabolismo , Animais , Western Blotting , Células Cultivadas , Citometria de Fluxo , Humanos , Peróxido de Hidrogênio/farmacologia , Camundongos , Mioblastos/citologia , Oxidantes/farmacologia , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Saccharomyces cerevisiae/crescimento & desenvolvimentoRESUMO
The finding that the heterologous expression of Bcl-2 proteins in yeast elicits effects that resemble their roles in metazoan apoptosis has contributed to the increasing use of this organism as a model for the study of apoptotic regulation. The pro-apoptotic Bax protein, for example, localizes to the yeast mitochondria, where it acts to promote alterations in mitochondrial physiology and cell death, similar to its ascribed mode of action in higher organisms. These observations lead to the hypothesis that the heterologous Bcl-2 proteins impinge on conserved elements of the apoptotic machinery in yeast. We herein provide a retrospective of the studies aimed at both testing this general hypothesis and investigating the mechanisms of the Bcl-2 proteins using yeast, with a particular emphasis on Bax. We also discuss the evidence for pleiotropic roles of Bax in yeast apoptosis.
Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Apoptose/fisiologia , Mitocôndrias/metabolismo , Leveduras/fisiologia , Proteína X Associada a bcl-2/metabolismo , Animais , Autofagia/fisiologia , Citocromos c/metabolismo , Estresse Oxidativo , Fosforilação , Príons/metabolismoRESUMO
Anti-apoptotic proteins are involved in modulating the process of apoptosis. Here, we report the identification of the previously uncharacterized transmembrane domain protein 85 (TMEM85) as a novel anti-apoptotic sequence. Using growth and viability assays, we demonstrate that the heterologous expression of human TMEM85 in yeast promotes growth and prevents cell death in response to oxidative stress. Overexpression of the yeast TMEM85 ortholog (YGL231c) also leads to increased resistance to oxidative stress. Analysis of the existing TMEM85 DNA complimentary to mRNAs revealed that the human TMEM85 gene is alternatively spliced to produce multiple transcripts and proteins. Thus TMEM85 is a complex gene that encodes a novel conserved anti-apoptotic protein.
Assuntos
Apoptose , Peróxido de Hidrogênio/metabolismo , Proteínas de Membrana/metabolismo , Estresse Oxidativo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/fisiologia , Processamento Alternativo , Sequência de Aminoácidos , Genoma Humano , Humanos , Peróxido de Hidrogênio/farmacologia , Proteínas de Membrana/genética , Dados de Sequência Molecular , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/genéticaRESUMO
Elucidating novel anti-apoptotic regulatory pathways is central to further understanding the molecular basis of several pathologies, including cancer. We have previously reported the identification of several mammalian cDNAs effective in preventing the lethal effects of heterologous expression of a pro-apoptotic BAX cDNA in yeast [Yang, Z., Khoury, C., Jean-Baptiste, G., Greenwood, M.T., 2006. Identification of mouse sphingomyelin synthase 1 (SMS1) as a suppressor of Bax mediated cell death in yeast. FEMS Yeast Res. 6, 751-762]. Here we report that one of the Bax suppressors encodes a novel 156 amino acid variant of the human Vps24 protein, Vps24beta, that lacks the N-terminal lipid binding domain of the well characterized 222 residue Vps24 (Vps24alpha). We demonstrate that the VPS24beta cDNA represents an expressed transcript that is likely produced by alternative splicing of the human VPS24 gene. Vps24alpha, but not Vps24beta, prevented the temperature and salt sensitive growth defects observed in a yeast mutant lacking a functional VPS24 gene. In contrast, Vps24beta, but not Vps24alpha, suppressed the inhibitory effects of Bax on yeast growth. Vps24beta protein also suppressed the effects of Bax in mutants lacking other VPS genes suggesting that a functional ESCRT pathway, of which the yeast Vps24p is an essential component, is not required for Vps24beta function. Taken together, we demonstrate that the human VPS24 gene gives rise to two functionally distinct proteins, one of which is involved in the ESCRT pathway and another novel protein that serves an anti-apoptotic role.
Assuntos
Processamento Alternativo , Proteínas de Transporte Vesicular/metabolismo , Leveduras/genética , Proteína X Associada a bcl-2/genética , Sequência de Aminoácidos , Animais , Divisão Celular/efeitos dos fármacos , Divisão Celular/genética , Linhagem Celular , Complexos Endossomais de Distribuição Requeridos para Transporte , Endossomos/metabolismo , Perfilação da Expressão Gênica , Teste de Complementação Genética , Células HeLa , Humanos , Peróxido de Hidrogênio/farmacologia , Camundongos , Dados de Sequência Molecular , Mutação , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Homologia de Sequência de Aminoácidos , Cloreto de Sódio/farmacologia , Transcrição Gênica , Proteínas de Transporte Vesicular/genética , Leveduras/crescimento & desenvolvimento , Leveduras/metabolismo , Proteína X Associada a bcl-2/metabolismoRESUMO
Phosphorylation of the alpha-subunit of the eukaryotic initiation factor 2 (eIF2) on Ser51 is an early event associated with the down-regulation of protein synthesis at the level of translation and initiation of a transcriptional program. This constitutes a potent mechanism to overcome various stress conditions. In mammals, four eIF2alpha-kinases [PKR-like endoplasmic reticulum kinase (PERK), dsRNA-activated protein kinase (PKR), heme regulated inhibitor (HRI) and general control nonderepressible-2 (GCN2)], activated following specific stresses, have been shown to be involved in this process. In this article, we report that the ubiquitously expressed adaptor protein Nck, composed only of Src homology domains and classically implicated in cell signaling by activated plasma membrane receptor tyrosine kinases, modulates eIF2alpha-kinase-mediated eIF2alphaSer51 phosphorylation in a specific manner. Our results show that Nck not only prevents eIF2alpha phosphorylation upon PERK activation, as reported previously, but also reduces eIF2alpha phosphorylation in conditions leading to PKR and HRI activation. By contrast, the overexpression of Nck in mammalian cells fails to attenuate eIF2alphaSer51 phosphorylation in response to amino acid starvation, a stress well known to activate GCN2. This observation is further confirmed by showing that Nck fails to alter eIF2alphaSer51 phosphorylation in Saccharomyces cerevisiae, for which the sole eIF2alpha-kinase is Gcn2p. Our results suggest the existence of a novel mechanism that specifically modulates the phosphorylation of eIF2alpha on Ser51 under various stress conditions.
Assuntos
Proteínas Adaptadoras de Transdução de Sinal/fisiologia , Fator de Iniciação 2 em Eucariotos/metabolismo , Proteínas Oncogênicas/fisiologia , Serina/metabolismo , eIF-2 Quinase/metabolismo , Fator de Iniciação 2 em Eucariotos/química , Células HeLa , Humanos , FosforilaçãoRESUMO
Sphingomyelin synthase 1 (SMS1) is a recently identified 413-residue protein that plays a critical role in sphingolipid metabolism by catalyzing the conversion of ceramide and phosphatidylcholine to sphingomyelin and diacylglycerol (DAG). We have previously reported the isolation of a mouse SMS1 encoding cDNA that contains a unique 5' UTR sequence. Three other mouse SMS1 cDNAs that differed in their 5' and 3' non-coding sequences were present in GenBank. In order to ascertain the origin of the unique 5' and 3' UTR sequences, we analyzed the structure of the mouse SMS1 gene. Analysis of the four different SMS1 cDNA sequences and of the corresponding mouse genomic fragment revealed that the SMS1 gene consists of 16 exons that are alternatively spliced to produce 4 different mRNAs (SMS1alpha1, SMS1alpha2, SMS1beta and SMS1gamma) and 3 different proteins (SMS1alpha, SMS1beta and SMS1gamma). RT-PCR was used to demonstrate that all four SMS1 cDNAs represent expressed transcripts that show distinctly different tissue distributions. Transcripts for SMS1alpha1, SMS1alpha2 and SMS1beta were found to increase in response to the pro-apoptotic effects of TNF-alpha. Finally, using a yeast-based assay, we confirmed that SMS1alpha prevents the growth inhibitory effects of Bax but SMS1beta neither prevents nor enhances the effects of Bax or of SMS1alpha. Taken together these results demonstrate the complexity of SMS1 gene structure, expression and function.
Assuntos
Processamento Alternativo , Transferases (Outros Grupos de Fosfato Substituídos)/genética , Animais , Sequência de Bases , Western Blotting , Linhagem Celular , DNA , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , RNA Mensageiro/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Saccharomyces cerevisiae/genética , Transferases (Outros Grupos de Fosfato Substituídos)/metabolismoRESUMO
G-protein coupled receptors (GPCRs) represent a large class of cell surface receptors that mediate a multitude of functions. Over the years, a number of GPCRs and ancillary proteins have been shown to be expressed in skeletal muscle. Unlike the case with other muscle tissues like cardiac and vascular smooth muscle cells, there has been little attempt at systematically analyzing GPCRs in skeletal muscle. Here we have compiled all the GPCRs that are expressed in skeletal muscle. In addition, we review the known function of these receptors in both skeletal muscle tissue and in cultured skeletal muscle cells.
Assuntos
Músculo Esquelético/fisiologia , Peptídeos/fisiologia , Receptores Acoplados a Proteínas G/fisiologia , Animais , Proteínas de Transporte/fisiologia , Células Cultivadas , Humanos , Músculo Esquelético/química , Peptídeos/química , Receptores Acoplados a Proteínas G/biossíntese , Transdução de Sinais/fisiologiaRESUMO
Previous investigations had suggested that signaling from the overexpressed beta(2) adrenergic in the heart of transgenic TG4 mice was dampened in the atria. Using an RT-PCR based strategy, we have identified Regulator of G-protein Signaling 5 (RGS5) as being up-regulated in the atria of TG4 mice. Northern blot analysis demonstrated that RGS5 levels were 3 fold higher in the atria of TG4 mice. Western blot analysis of a panel of rat tissues demonstrated that basal expression of RGS5 protein was confined to the heart and skeletal muscle. Furthermore, RGS5 protein was detected in skeletal muscle C2C12 and cardiomyocyte HL-1 cultured cell lines. As observed for RGS5 mRNA levels in TG4 mice, RGS5 protein levels were increased in the atria of rats that were administered the beta adrenergic agonist isoproterenol during a 14 day period. Taken together, these results indicate that RGS5 is a housekeeping RGS in the heart and in skeletal muscle while its beta adrenergic-mediated induction in the atrium suggests that it also has a highly specialized function.
Assuntos
Miocárdio/metabolismo , Proteínas RGS/biossíntese , Receptores Adrenérgicos beta/fisiologia , Agonistas Adrenérgicos beta/farmacologia , Animais , Northern Blotting , Western Blotting , Células Cultivadas , Eletroforese em Gel de Poliacrilamida , Proteínas do Olho/imunologia , Átrios do Coração/efeitos dos fármacos , Átrios do Coração/metabolismo , Humanos , Isoproterenol/farmacologia , Masculino , Camundongos , Camundongos Transgênicos , Proteínas RGS/imunologia , Ratos , Ratos Sprague-Dawley , Receptores Adrenérgicos beta/efeitos dos fármacos , Receptores Acoplados a Proteínas G/efeitos dos fármacos , Receptores Acoplados a Proteínas G/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Distribuição Tecidual , Regulação para Cima/efeitos dos fármacosRESUMO
The human Thyroid Cancer-1 (hTC-1) protein, also known as C8orf4 was initially identified as a gene that was up-regulated in human thyroid cancer. Here we show that hTC-1 is a peptide that prevents the effects of over-expressing Bax in yeast. Analysis of the 106 residues of hTC-1 in available protein databases revealed direct orthologues in jawed-vertebrates, including mammals, frogs, fish and sharks. No TC-1 orthologue was detected in lower organisms, including yeast. Here we show that TC-1 is a general pro-survival peptide since it prevents the growth- and cell death-inducing effects of copper in yeast. Human TC-1 also prevented the deleterious effects that occur due to the over-expression of a number of key pro-apoptotic peptides, including YCA1, YBH3, NUC1, and AIF1. Even though the protective effects were more pronounced with the over-expression of YBH3 and YCA1, hTC-1 could still protect yeast mutants lacking YBH3 and YCA1 from the effects of copper sulfate. This suggests that the protective effects of TC-1 are not limited to specific pathways or processes. Taken together, our results indicate that hTC-1 is a pro-survival protein that retains its function when heterologously expressed in yeast. Thus yeast is a useful model to characterize the potential roles in cell death and survival of cancer related genes.
RESUMO
Genetically programmed cell death (PCD) mechanisms, including apoptosis, are important for the survival of metazoans since it allows, among things, the removal of damaged cells that interfere with normal function. Cell death due to PCD is observed in normal processes such as aging and in a number of pathophysiologies including hypoxia (common causes of heart attacks and strokes) and subsequent tissue reperfusion. Conversely, the loss of normal apoptotic responses is associated with the development of tumors. So far, limited success in preventing unwanted PCD has been reported with current therapeutic approaches despite the fact that inhibitors of key apoptotic inducers such as caspases have been developed. Alternative approaches have focused on mimicking anti-apoptotic processes observed in cells displaying increased resistance to apoptotic stimuli. Hormesis and pre-conditioning are commonly observed cellular strategies where sub-lethal levels of pro-apoptotic stimuli lead to increased resistance to higher or lethal levels of stress. Increased expression of anti-apoptotic sequences is a common mechanism mediating these protective effects. The relevance of the latter observation is exemplified by the observation that transgenic mice overexpressing anti-apoptotic genes show significant reductions in tissue damage following ischemia. Thus strategies aimed at increasing the levels of anti-apoptotic proteins, using gene therapy or cell penetrating recombinant proteins are being evaluated as novel therapeutics to decrease cell death following acute periods of cell death inducing stress. In spite of its functional and therapeutic importance, more is known regarding the processes involved in apoptosis than anti-apoptosis. The genetically tractable yeast Saccharomyces cerevisiae has emerged as an exceptional model to study multiple aspects of PCD including the mitochondrial mediated apoptosis observed in metazoans. To increase our knowledge of the process of anti-apoptosis, we screened a human heart cDNA expression library in yeast cells undergoing PCD due to the conditional expression of a mammalian pro-apoptotic Bax cDNA. Analysis of the multiple Bax suppressors identified revealed several previously known as well as a large number of clones representing potential novel anti-apoptotic sequences. The focus of this review is to report on recent achievements in the use of humanized yeast in genetic screens to identify novel stress-induced PCD suppressors, supporting the use of yeast as a unicellular model organism to elucidate anti-apoptotic and cell survival mechanisms.
RESUMO
Obesity is characterised by lipid accumulation in non-adipose tissues, leading to organ degeneration and a wide range of diseases, including diabetes, heart attack and liver cirrhosis. Free fatty acids (FFA) are believed to be the principal toxic triggers mediating the adverse cellular effects of lipids. Here, we show that various cooking oils used in human nutrition cause cell death in yeast in the presence of a triacylglycerol lipase, mimicking the physiological microenvironment of the small intestine. Combining genetic and cell death assays, we demonstrate that elevated FFA concentrations lead to necrotic cell death, as evidenced by loss of membrane integrity and release of nuclear HMGB1. FFA-mediated necrosis depends on functional mitochondria and leads to the accumulation of reactive oxygen species. We conclude that lipotoxicity is executed via a mitochondrial necrotic pathway, challenging the dogma that the adverse effects of lipid stress are exclusively apoptotic.
Assuntos
Ácidos Graxos não Esterificados/toxicidade , Mitocôndrias/efeitos dos fármacos , Necrose/induzido quimicamente , Saccharomyces cerevisiae/efeitos dos fármacos , Apoptose , Proteína HMGB1/metabolismo , Lipase/metabolismo , Mitocôndrias/metabolismo , Necrose/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismoRESUMO
The apoptotic programme is evolutionarily conserved between yeast and metazoan organisms. We have previously identified a number of mammalian cDNAs capable of suppressing the deleterious effects of Bax expression in yeast. We herein report that one such suppressor, named Tsc22((86)), represents the C-terminal 86 amino acids of the previously characterized leucine zipper (LZ) motif-containing transcriptional regulator Tsc22. Employing a genome-wide two-hybrid screen, functional genomics, and deletion mutagenesis approaches, we conclude that Tsc22((86))-mediated antiapoptosis is independent of the LZ motif and is likely independent of effects on gene transcription. Rather, a 16-residue sequence within the conserved 56-residue TSC22 domain is necessary for antiapoptosis. The presence of a similar sequence was used to predict an antiapoptotic role for two yeast proteins, Sno1p and Fyv10p. Overexpression and knock-out experiments were used to validate this prediction. These findings demonstrate the potential of studying heterologous proteins in yeast to uncover novel biological insights into the regulation of apoptosis.
Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/fisiologia , Motivos de Aminoácidos , Sequência de Aminoácidos , Proteínas Reguladoras de Apoptose/química , Proteínas Reguladoras de Apoptose/genética , Sequência Conservada , Deleção de Genes , Dosagem de Genes , Viabilidade Microbiana , Dados de Sequência Molecular , Estrutura Terciária de Proteína , Saccharomyces cerevisiae/crescimento & desenvolvimento , Proteínas de Saccharomyces cerevisiae/química , Proteínas de Saccharomyces cerevisiae/genética , Homologia de Sequência de Aminoácidos , Técnicas do Sistema de Duplo-HíbridoRESUMO
We have identified mouse sphingomyelin synthase 1 as a novel suppressor of the growth inhibitory effect of heterologously expressed Bax. Yeast cells expressing sphingomyelin synthase 1 were also found to show an increased resistance to a variety of cytotoxic stimuli including hydrogen peroxide, osmotic stress and elevated temperature. Sphingomyelin synthase 1 functions by catalyzing the conversion of ceramide and phosphatidylcholine to sphingomyelin and diacylglycerol. Ceramide is an antiproliferative and proapoptotic sphingolipid whose level increases in response to a variety of stresses. Consistent with its biochemical function, yeast cells expressing sphingomyelin synthase 1 have an enhanced ability to grow in media containing the cell-permeable C2-ceramide analog as well as the ceramide precursor phytosphingosine. We also show that overexpression of AUR1, a potential yeast functional homolog of sphingomyelin synthase, also protects cells from osmotic stress. Taken together, these results suggest that sphingomyelin synthase 1 likely prevents cell death by counteracting stress-mediated accumulation of endogenous sphingolipids.
Assuntos
Apoptose , Saccharomyces cerevisiae/crescimento & desenvolvimento , Transferases (Outros Grupos de Fosfato Substituídos)/fisiologia , Proteína X Associada a bcl-2/antagonistas & inibidores , Animais , Ceramidas/farmacologia , Hexosiltransferases/fisiologia , Temperatura Alta , Peróxido de Hidrogênio/farmacologia , Camundongos , Concentração Osmolar , Saccharomyces cerevisiae/efeitos dos fármacos , Esfingosina/análogos & derivados , Esfingosina/farmacologiaRESUMO
Lysophosphatidic acid (LPA) is a potent modulator of growth, cell survival, and apoptosis. Although all four LPA receptors are expressed in skeletal muscle, very little is known regarding the role they play in this tissue. We used RT-PCR to demonstrate that cultured skeletal muscle C2C12 cells endogenously express multiple LPA receptor subtypes. The demonstration that LPA mediates the activation of ERK1/2 MAP kinase and Akt/PKB in C2C12 cells is consistent with the widely observed mitogenic properties of LPA. In spite of these observations, LPA did not induce proliferation in C2C12 cells. Paradoxically, we found that prolonged treatment of C2C12 cells with LPA led to caspase 3 and PARP cleavage as well as the activation of stress-associated MAP kinases JNK and p38. In spite of these typically pro-apoptotic responses, LPA did not induce cell death. Blocking ERK1/2 and Akt/PKB activation with specific pharmacological inhibitors, nevertheless, stimulated LPA-mediated apoptosis. Taken together, these results suggest that both mitogenic and apoptotic responses serve to counterbalance the effects of LPA in cultured C2C12 cells.